logo

For the Inventor, By the Inventor

Doylestown, PA, United States of America

Walter R Strapps

LinkedIn

This inventor holds 21 USPTO granted patents and 12 published patent applications and 1 EPO patent, primarily in Gene Editing Technology. Top assignees: Sirna Therapeutics, Inc., Intellia Therapeutics, Inc., Merck Sharp + Dohme Corp.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter R Strapps. Retrieved from https://idiyas.com/inventor/walter-r-strapps

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 57(Granted Patents)


Location History:

  • San Mateo, CA (US) (2013)
  • Doylestown, PA (US) (2013 - 2024)
  • Dedham, MA (US) (2018 - 2024)

Company Filing History:

goldMedal9 out of 140 
 
Sirna Therapeutics, Inc.
 patents
silverMedal8 out of 20 
 
Intellia Therapeutics, Inc.
 patents
bronzeMedal2 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
4. 1 out of 5 
 
Sima Therapeutics, Inc.
 patents
5. 1 out of 834,513 
Other
 patents

Years Active: 2013-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Gene Editing
Guide RNAs
RNA Interference
Alpha-1 Antitrypsin Deficiency
ATTR Amyloidosis
PHD2 Gene Expression
CTNNB1 Gene Expression
Systemic Delivery
Short Interfering Nucleic Acids
Polynucleotide Compositions
Myostatin Inhibition
TTR Gene Editing
21 patents (USPTO):Explore Patents
1. 12735698 - Modified Guide RNAs (2026-09-15),
2. 12686876 - Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding Agent (2026-07-21),
3. 12460205 - Compositions and methods for treating alpha-1 antitrypsin deficiency (2025-11-04),
4. 12173284 - Modified guide RNAs (2024-12-24),
5. 11965165 - Compositions and methods for TTR gene editing and treating ATTR amyloidosis (2024-04-23),
6. 11952573 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA) (2024-04-09),
7. 11795460 - Compositions and methods for TTR gene editing and treating ATTR amyloidosis (2023-10-24),
8. 11549107 - Compositions and methods for treating alpha-1 antitrypsin deficiency (2023-01-10),
9. 11529428 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2022-12-20),
10. 11479767 - Modified guide RNAs (2022-10-25),
11. 11332745 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (SINA) (2022-05-17),
12. 10729787 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2020-08-04),
13. 10577606 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA) (2020-03-03),
14. 10246714 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) (2019-04-02),
15. 10004814 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2018-06-26),

Title: The Innovative Journey of Walter R. Strapps

Introduction: Walter R. Strapps, a distinguished inventor hailing from Doylestown, PA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Walter R. Strapps holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: With a career spanning over two decades, Walter R. Strapps has been at the forefront of innovation, leading research teams and spearheading projects that have revolutionized industries.

Collaborations: Throughout his career, Walter R. Strapps has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, showcasing his ability to work across disciplines and sectors.

Conclusion: Walter R. Strapps' relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a visionary inventor, inspiring the next generation of innovators to dream big and create a better future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…